Automated External Defibrillator Aed Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The global AED market encompasses devices sold for use in hospitals, ambulances, workplaces, schools, airports, and private homes, spanning both semi-automatic and fully automatic variants with increasingly integrated connectivity features. Valued at roughly $1.27 billion in 2025, the market has been expanding steadily as awareness of sudden cardiac arrest survival rates, which improve dramatically with early defibrillation, drives institutional purchasing and consumer adoption. Government initiatives such as the European Resuscitation Council guidelines and U.S. Cardiac Arrest Survival Act have played a significant role in normalizing public AED deployment.

• •Market valued at ~$1.27 billion in 2025 with 8.1% CAGR
• •Devices range from basic portable units to advanced models with ECG and CPR guidance
• •Regulatory mandates and public access programs are key institutional demand drivers

Rising global burden of cardiovascular disease, the leading cause of death worldwide, combined with aging demographics in developed and developing economies creates a structural tailwind for AED adoption. Advances in device usability, such as voice prompts, real-time CPR feedback, and reduced device weight, have lowered the barrier to non-medical use, expanding the potential user base. Additionally, workplace safety regulations and expanding public access defibrillation (PAD) legislation in regions including the EU, U.S., Japan, and increasingly India and Southeast Asia are compelling organizations to procure AEDs.

• •Cardiovascular disease prevalence and aging populations increase cardiac arrest incidents
• •Technology improvements make AEDs more accessible to untrained bystanders
• •PAD legislation and workplace safety mandates expand institutional purchasing requirements

The market is typically segmented by product type (semi-automatic vs. fully automatic), end-use setting (public access vs. professional/clinical), and distribution channel (direct institutional sales, retail, and online). Geographically, North America leads in market share due to established regulatory frameworks, high healthcare spending, and extensive public PAD programs. Europe follows closely, driven by EU-level resuscitation guidelines and national mandates. The Asia-Pacific region is the fastest-growing segment, fueled by rising healthcare investment, growing cardiac disease burden, and government-led defibrillation initiatives in countries like China, India, Japan, and Australia.

• •North America holds the largest share; Europe is a strong second
• •Asia-Pacific is the fastest-growing region due to healthcare infrastructure expansion
• •Public access and home-use segments are growing faster than traditional clinical sales

Who are the notable companies in the industry?

The global AED market is shaped by a competitive landscape spanning diversified medical technology conglomerates and focused cardiac device specialists. Philips anchors its position through the established HeartStart platform and the legacy infrastructure of Physio-Control, giving it formidable reach across both institutional procurement and public-access programs. ZOLL Medical Corporation differentiates through clinical integration and comprehensive resuscitation technologies that extend beyond the defibrillator itself. Cardiac Science Corporation and Defibtech, LLC compete on device durability, service reliability, and entrenched distribution partnerships across municipal and corporate buyers. Meanwhile, Avive Solutions, Inc. represents an emergent wave of challengers, leveraging agile design and consumer-facing connectivity to expand community-level deployment models. Competition increasingly pivots on algorithmic guidance sophistication, networked data ecosystems, and regulatory footprint, with leading players balancing technological innovation against the price sensitivity and regulatory fragmentation that characterize developing-market expansion.

• •Philips, ZOLL Medical, and Physio-Control (Stryker) are established market leaders
• •Cardiac Science and Defibtech hold strong positions in public access and home segments
• •Boston Scientific and other med-tech giants compete via integrated cardiac care portfolios

What are the recent trends and outlook?

Key trends shaping the market include the integration of AEDs with smartphone apps and IoT platforms for maintenance monitoring and incident reporting, the development of pediatric-capable and multi-language devices, and a growing emphasis on training and community awareness programs bundled with device sales. Looking ahead, the convergence of wearable cardiac monitoring with AED technology, evolving reimbursement policies, and expanded CPR/AED education mandates are expected to sustain above-average growth through 2030 and beyond, with the market potentially doubling within the decade if current trajectories hold.

• •IoT connectivity and app integration for device tracking and incident management are rising
• •Wearable-AED convergence and pediatric-capable devices represent emerging innovation fronts
• •Continued growth expected as global PAD mandates and cardiovascular disease burden expand